Close
Mar. 31, 2023 News Release
Notice Regarding Disclosures Based on the TCFD Recommendations
Mar. 31, 2023 Financial Results
Partial Correction of “Summary of Consolidated Financial Statements for the Year Ended December 31, 2022 [IFRS]”
Mar. 01, 2023 Update
Announcing the Convocation of the Annual Meeting of Shareholders for the Year Ended December 31, 2022
Mar. 01, 2023 Update
IR Calendar
Feb. 28, 2023 News Release
Notice of Planned Additional Investment in Bangladesh Joint Venture (Subsidiary)
Feb. 14, 2023 Financial Results
Video Streaming of Results Presentation (Including Q&A) for the Fiscal Year Ended December 31, 2022
Feb. 13, 2023 Financial Results
Summary of Consolidated Financial Statements for Fiscal 2022
Feb. 13, 2023 Financial Results
Supplementary Materials of Financial Results for Fiscal 2022
Feb. 13, 2023 News Release
Notice Concerning Changes in Corporate Management and Representative Directors
Feb. 13, 2023 News Release
Notice Concerning Changes in Directors and Audit & Supervisory Board Members
Feb. 13, 2023 Update
IR Calendar
Jan. 31, 2023 News Release
Lion to Establish Research and Development Subsidiary in China
Jan. 16, 2023 News Release
Notice Concerning the Acquisition of Shares of Vietnam-Based MERAP HOLDING CORPORATION
Dec. 15, 2022 News Release
Lion Corporation Selected for Inclusion in the Dow Jones Sustainability Asia/Pacific Index for a Sixth Consecutive Year
Dec. 06, 2022 Update
IR Calender
Dec. 02, 2022 Update
Video Streaming of Management Strategy and New Product Launch Presentation
Nov. 30, 2022 News Release
Date of Relocation of Lion Head Office Decided
Nov. 30, 2022 News Release
Lion to Construct New Over-the-Counter Drug Factory
Nov. 14, 2022 Financial Results
Analyst Q&A (Summary) from the Conference Call for the First Nine Months of Fiscal 2022
Nov. 07, 2022 Financial Results
Audio Streaming of Results Presentation (Including Q&A) for the First Nine Months of Fiscal 2022